Mr. Scodari has served as a director of Acurx since July 2021. Since October 2017 he has been Chairman of the Board of Optinose (Nasdaq: OPTN). He previously served as Worldwide Chairman of Johnson & Johnson's Pharmaceuticals Group and a member of its Executive Committee from March 2005 until his retirement in March 2008, and from 2003 to 2005 as Company Group Chairman of J&J's Biopharmaceutical Business. He joined Centocor Inc. in 1996 as President of its Pharmaceutical Division and was named President and Chief Operating Officer in 1998, serving until Centocor's 1999 acquisition by Johnson & Johnson. He previously served as a director of Actelion Pharmaceuticals, Endo Health Solutions and Covance. Mr. Scodari received a B.A. from Youngstown State University.